Suppr超能文献

HIV-1 感染者病毒血症中的疾病进展。

Disease Progression in HIV-1-Infected Viremic Controllers.

机构信息

Centre for Immunology and Infectious Disease, Blizard Institute, Queen Mary University of London.

出版信息

J Acquir Immune Defic Syndr. 2012 Dec 1;61(4):407-16. doi: 10.1097/QAI.0b013e318269c414.

Abstract

BACKGROUND

The mechanism of CD4 T-cell decline in HIV-1 infection is unclear, but the association with plasma viral RNA load suggests viral replication is involved. Indeed, viremic controller patients with low viral RNA loads typically maintain high CD4 T-cell counts. Within a local cohort of 86 viremic controllers, we identify a subgroup (18 "discord controllers") with low CD4 T-cell counts that present clinical uncertainty. The underlying mechanism accounting for CD4 T-cell decline in the face of low or undetectable plasma (RNA) viral load remains unresolved. The objective of this study was to investigate the viral and host immune system dynamics in discord controllers by measuring cellular HIV-1 DNA load, T-cell populations, and T-cell activation markers.

METHODS

We compared discord controllers (viral RNA load <2000 copies/mL, <450 CD4 T-cells/mm) with typical controllers (viral RNA load <2000 copies/mL, >450 CD4 T-cells/mm) and progressors (viral RNA load >10,000 copies/mL, <450 CD4 T-cells/mm). We quantified CD4/CD8 naive/central memory/effector memory subsets (CD45RA/RO ± CD62L), activation levels (CD38HLA-DR), and HIV-1 DNA load.

RESULTS

Discord controllers resembled progressors showing high viral DNA load, depletion of naive CD4 T-cells, and higher activation in all CD4 T-cell subsets, compared with typical controllers. They were similar to typical controllers with lower CD8 T-cell activation compared with progressors.

CONCLUSIONS

Our data are consistent with a relationship between CD4 T-cell activation and disease progression. HIV-1 DNA load may be a better marker of viral replication and disease progression than viral RNA load. Lower level CD8 T-cell activation correlates with low viral RNA load but not with disease progression or viral DNA load.

摘要

背景

在 HIV-1 感染中,CD4 T 细胞下降的机制尚不清楚,但与血浆病毒 RNA 载量的关联表明病毒复制可能涉及其中。事实上,病毒血症控制者的病毒载量较低,通常会维持较高的 CD4 T 细胞计数。在当地的 86 名病毒血症控制者队列中,我们发现了一个亚组(18 名“不一致控制者”)的 CD4 T 细胞计数较低,存在临床不确定性。在面对低或无法检测到的血浆(RNA)病毒载量的情况下,导致 CD4 T 细胞下降的潜在机制仍未解决。本研究的目的是通过测量细胞 HIV-1 DNA 载量、T 细胞群和 T 细胞激活标志物,来研究不一致控制者中的病毒和宿主免疫系统动态。

方法

我们比较了不一致控制者(病毒 RNA 载量 <2000 拷贝/mL,<450 CD4 T 细胞/mm)与典型控制者(病毒 RNA 载量 <2000 拷贝/mL,>450 CD4 T 细胞/mm)和进展者(病毒 RNA 载量>10,000 拷贝/mL,<450 CD4 T 细胞/mm)。我们量化了 CD4/CD8 幼稚/中央记忆/效应记忆亚群(CD45RA/RO±CD62L)、激活水平(CD38HLA-DR)和 HIV-1 DNA 载量。

结果

与典型控制者相比,不一致控制者与进展者相似,表现出高病毒 DNA 载量、幼稚 CD4 T 细胞耗竭以及所有 CD4 T 细胞亚群的高激活。与进展者相比,他们与典型控制者的 CD8 T 细胞激活水平较低。

结论

我们的数据与 CD4 T 细胞激活与疾病进展之间的关系一致。HIV-1 DNA 载量可能是比病毒 RNA 载量更好的病毒复制和疾病进展标志物。较低水平的 CD8 T 细胞激活与低病毒 RNA 载量相关,但与疾病进展或病毒 DNA 载量无关。

相似文献

1
Disease Progression in HIV-1-Infected Viremic Controllers.
J Acquir Immune Defic Syndr. 2012 Dec 1;61(4):407-16. doi: 10.1097/QAI.0b013e318269c414.
2
Immune Activation and HIV-Specific CD8(+) T Cells in Cerebrospinal Fluid of HIV Controllers and Noncontrollers.
AIDS Res Hum Retroviruses. 2016 Aug;32(8):791-800. doi: 10.1089/AID.2015.0313. Epub 2016 May 2.
3
HIV-specific CD4+ T cells may contribute to viral persistence in HIV controllers.
Clin Infect Dis. 2011 Mar 1;52(5):681-7. doi: 10.1093/cid/ciq202. Epub 2011 Jan 18.
5
Naïve and memory CD4+ T cells and T cell activation markers in HIV-1 infected children on HAART.
Clin Exp Immunol. 2001 Aug;125(2):266-73. doi: 10.1046/j.1365-2249.2001.01612.x.
7
Human Immunodeficiency Virus Type-1 Elite Controllers Maintain Low Co-Expression of Inhibitory Receptors on CD4+ T Cells.
Front Immunol. 2018 Jan 22;9:19. doi: 10.3389/fimmu.2018.00019. eCollection 2018.
8
CD4 T-cell regeneration in HIV-1 elite controllers.
AIDS. 2012 Mar 27;26(6):701-6. doi: 10.1097/QAD.0b013e3283519b22.

引用本文的文献

1
HIV-1 control in vivo is related to the number but not the fraction of infected cells with viral unspliced RNA.
Proc Natl Acad Sci U S A. 2024 Sep 3;121(36):e2405210121. doi: 10.1073/pnas.2405210121. Epub 2024 Aug 27.
4
Extremely low viral reservoir in treated chronically HIV-1-infected individuals.
EBioMedicine. 2020 Jul;57:102830. doi: 10.1016/j.ebiom.2020.102830. Epub 2020 Jun 21.
6
Proviral Quasispecies Diversity Is Not Associated With Virologic Breakthrough or CD4 T Cell Loss in HIV-1 Elite Controllers.
Front Microbiol. 2019 Apr 2;10:673. doi: 10.3389/fmicb.2019.00673. eCollection 2019.
7
Harnessing CD8 T Cells Under HIV Antiretroviral Therapy.
Front Immunol. 2019 Feb 26;10:291. doi: 10.3389/fimmu.2019.00291. eCollection 2019.
8
Natural control of HIV infection in young women in South Africa: HPTN 068.
HIV Clin Trials. 2018 Oct;19(5):202-208. doi: 10.1080/15284336.2018.1531534. Epub 2018 Dec 6.
9
Higher prevalence of viral control in HIV-1-infected women in serodiscordant relationships.
PLoS One. 2018 Dec 5;13(12):e0208401. doi: 10.1371/journal.pone.0208401. eCollection 2018.

本文引用的文献

1
Are long-term non-progressors very slow progressors? Insights from the Chelsea and Westminster HIV cohort, 1988-2010.
PLoS One. 2012;7(2):e29844. doi: 10.1371/journal.pone.0029844. Epub 2012 Feb 20.
2
Elite controllers display higher activation on central memory CD8 T cells than HIV patients successfully on HAART.
AIDS Res Hum Retroviruses. 2011 Feb;27(2):157-65. doi: 10.1089/aid.2010.0107. Epub 2010 Oct 21.
4
CD4 T cell count reconstitution in HIV controllers after highly active antiretroviral therapy.
Clin Infect Dis. 2010 Apr 15;50(8):1187-91. doi: 10.1086/651421.
5
Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies.
Lancet. 2009 Apr 18;373(9672):1352-63. doi: 10.1016/S0140-6736(09)60612-7. Epub 2009 Apr 8.
10
Understanding the benign nature of SIV infection in natural hosts.
J Clin Invest. 2007 Nov;117(11):3148-54. doi: 10.1172/JCI33034.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验